Cell Signaling Technology

FXR1 (L662) Antibody

#4264 · $317

100
Citing papers
10.4k
Combined citations
Supplier page Find this product

Research areas

Hippo pathway signaling and YAP/TAZ10PI3K/AKT/mTOR signaling in cancer9interferon and immune responses6Cancer Cells and Metastasis5Wnt/β-catenin signaling in development and cancer5Immune Cell Function and Interaction4Heat shock proteins research4Endoplasmic Reticulum Stress and Disease4

Papers citing this product

1
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
Nature·2021·781 cit.·DOI
2
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
Proceedings of the National Academy of Sciences·2017·407 cit.·DOI
3
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Genes & Development·2013·339 cit.·DOI
4
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Nature Communications·2017·290 cit.·DOI
5
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
Nature Communications·2017·243 cit.·DOI
6
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
Nature Communications·2017·235 cit.·DOI
7
Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells
Cancer Research·2005·216 cit.·DOI
8
EGFR oligomerization organizes kinase-active dimers into competent signalling platforms
Nature Communications·2016·210 cit.·DOI
9
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
bioRxiv (Cold Spring Harbor Laboratory)·2020·207 cit.·DOI
10
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV
bioRxiv (Cold Spring Harbor Laboratory)·2020·188 cit.·DOI

Similar products

ProductVendorPricePapers
FXR1 AntibodyRabbitCell Signaling Technology$317100
FXR1 (D10A2) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$16179
FXR1 (L662) Antibody — Evidence — PubIndex